Protect Pharmaceutical Corporation
Protect Pharmaceutical Corporation (PRTT) Stock Overview
Explore Protect Pharmaceutical Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
59.7M
P/E Ratio
0.99
EPS (TTM)
$-0.02
ROE
0.20%
PRTT Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Protect Pharmaceutical Corporation (PRTT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $1.32.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.99 and a market capitalization of 59.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. It acquires the Can Noguera property located in Selva Girona region in Spain. Its property consists of 60 hectares of arable land, 390 hectares of forests, 6 mineral and freshwater wells, and 3000 square meters of built properties. The company was formerly known as Pro-Tect, Inc. and changed its name to Protect Pharmaceutical Corporation in March 2010. Protect Pharmaceutical Corporation was founded in 1987 and is based in Las Vegas, Nevada.
Alan Crooks
4876 Cecile Avenue, Las Vegas, NV
2006